The association between lumbar disc herniation and erectile dysfunction is one of the most consistently documented and least frequently discussed findings in spine medicine. A man presents to a neurosurgical clinic with six months of sciatica, an MRI showing an L5–S1 extrusion, and a treatment conversation that covers pain, walking distance, and work capacity — but not sexual function. When investigators bother to ask, the numbers are striking. In a 2025 prospective study of 247 consecutive patients with degenerative lumbar spine disorders, 55% of the men met criteria for erectile dysfunction on the IIEF-5, and severity tracked independently with functional disability after adjustment for age.[1] This is not a coincidental overlap of two common conditions in middle-aged men. The nerve roots that carry sensation and autonomic signalling to the pelvis run through the same anatomical corridor that a herniated disc compresses.
The Shared Anatomy: Why the Lower Lumbar Spine Matters
Erection is a neurovascular event requiring the coordination of three separate pathways. Parasympathetic outflow from S2–S4 drives cavernosal smooth muscle relaxation via nitric oxide. Sympathetic fibres from T11–L2 govern detumescence and ejaculatory timing. Somatosensory afferents from the pudendal nerve, which arises from S2–S4, carry the genital sensation that initiates and sustains reflexogenic erection. All three converge in the lumbosacral region.
A posterolateral disc herniation at L4–L5 or L5–S1 — the two most common levels — sits directly against the traversing L5 and S1 roots. Extruded fragments can also compress the descending sacral roots within the thecal sac. Researchers at Ankara City Hospital framed the mechanism plainly: the nerves formed by the lower lumbar plexus provide the innervation of the urogenital organs, and lower lumbar disc herniation may impair the neuroregulation of sexual function by compressing those neural structures.[2] The pathway is mechanical before it is vascular, which distinguishes this form of erectile dysfunction from the endothelial disease that accounts for most cases in men over 50.
What the Prevalence Data Actually Show
The most rigorous synthesis available is a 2025 systematic review in BMC Musculoskeletal Disorders, which screened 5,893 records and retained 20 studies, 90% of which were rated high quality. Across this literature, the prevalence of sexual dysfunction in patients with lumbar disc herniation or cauda equina syndrome ranged from 26.6% to 100%. Erectile dysfunction was the most prevalent disorder among men, reported in 14% to 100% of cohorts, and 69% of men reported dissatisfaction with sexual activity.[3]
The extraordinary width of those ranges reflects heterogeneity in severity — a contained L4–L5 protrusion is not cauda equina syndrome — and in how sexual function was measured. Studies using the validated IIEF-5 tend to report the higher figures. In a prospective series of 61 patients undergoing single-level microdiscectomy, 38 of 41 men (92.7%) had preoperative sexual dysfunction by IIEF-5 score.[2] An earlier study of 43 patients found that 55% of men reported new sexual problems after the onset of low-back pain, with erectile dysfunction and premature ejaculation together accounting for 18% of complaints and decreased desire for another 18%. Intercourse frequency had fallen in 78% of cases compared with their pain-free baseline.[4]
Disentangling Nerve Compression From Pain, Fear, and Mood
Not all of this is neurogenic, and the honest reading of the evidence requires separating several overlapping contributors.
Mechanical pain and positional avoidance. Intercourse loads the lumbar spine. Men with radicular pain frequently reduce or abandon sexual activity to avoid provoking symptoms, and reduced frequency is itself associated with worsening erectile function over time.
Kinesiophobia. Fear of re-injury is a well-characterised driver of disability in chronic low-back pain, and it extends to sexual activity. Patients often report they were never told what was safe.
Depression. In the Heidelberg cohort, 42.2% of patients had moderate-to-severe depressive symptoms on the PHQ-9, and depression severity was the strongest single predictor of disability.[1] Depression independently reduces libido and erectile function, and the direction of causation is bidirectional.
Medication. Opioids prescribed for radicular pain suppress gonadotropin-releasing hormone and lower testosterone; gabapentinoids and some muscle relaxants add central sedation.
True neurogenic injury. Perianal sensory deficit, saddle anaesthesia, loss of the bulbocavernosus reflex, or sphincter disturbance point to sacral root involvement rather than pain avoidance. These findings are red flags requiring urgent evaluation.
A particularly instructive case series described four patients — two men, two women — presenting with sexual and sphincter dysfunction and perianal sensory deficit from large L5–S1 extruded fragments, in the complete absence of back pain or motor weakness.[5] Sexual dysfunction was the presenting symptom. The absence of pain does not exclude a structurally significant herniation.
Does Treating the Disc Improve Erectile Function?
Partially, and the qualifier matters. The 2025 systematic review found that sexual function improved after surgery in 83.33% of lumbar disc herniation studies (5 of 6), with improvement rates of 68% to 99%. The contrast with cauda equina syndrome was stark: only 1 of 14 studies (7.14%) showed improvement, and long-term follow-up found 14% to 100% of these patients with persistent sexual dysfunction.[3]
The microdiscectomy series is consistent with this. Of 38 men with preoperative sexual dysfunction, 26 (68.4%) improved postoperatively, a statistically significant change (p < 0.001) — but roughly a third did not.[2] In a separate pre-post study of 32 men using the Golombok-Rust Inventory, pain scores fell dramatically (VAS 8.18 to 1.28), yet the improvement in sexual sub-domains was limited largely to communication, with impotence and premature ejaculation sub-scores showing less movement.[6] Pain relief and erectile recovery are not the same endpoint.
The clinical implication is that decompression addresses the compressive component. It does not reverse established axonal injury, nor does it treat the depression, deconditioning, relationship strain, and coexisting vascular disease that accumulated during months or years of symptoms. Men whose erectile dysfunction persists after successful spinal surgery are not treatment failures; they have a second, separable problem that requires its own assessment.
How Neurogenic Erectile Dysfunction Differs in Treatment Response
PDE5 inhibitors work downstream of nitric oxide release. They amplify a signal; they do not generate one. Where the neural input to the cavernosal tissue is degraded — as in spinal cord injury, radical prostatectomy, diabetic autonomic neuropathy, or significant sacral root compromise — response rates to standard-dose single-agent therapy are meaningfully lower than in men with purely vascular disease, and higher doses or longer trials are often required.
This is the rationale behind formulations that engage more than one point in the pathway. Combining two PDE5 inhibitors with different pharmacokinetic profiles broadens the peripheral window. Agents acting on central dopaminergic pathways, such as apomorphine, initiate the pro-erectile signal in the paraventricular nucleus of the hypothalamus rather than amplifying a peripheral one — a mechanistically distinct target when the descending signal is the limiting factor. Sublingual routes bypass first-pass metabolism and shorten onset, which matters for men whose symptom burden is intermittent and positionally dependent. None of this is a substitute for diagnosing the underlying lesion, and anyone with saddle anaesthesia, new sphincter dysfunction, or progressive weakness needs imaging and a surgical opinion before anything else. Related discussions of vascular, neurological, and metabolic contributors are collected on the OnyxMD blog.
Conclusion
Lumbar disc herniation and erectile dysfunction are linked by anatomy, not coincidence. Prevalence figures in surgical cohorts run from roughly a quarter to nearly all patients depending on severity and measurement, and erectile dysfunction severity tracks independently with functional disability. Decompression improves sexual function in most patients with straightforward disc herniation, and in very few with cauda equina syndrome. A substantial minority — around one in three in the best prospective data — continue to have erectile difficulty after the spine is successfully treated, reflecting residual neural injury compounded by mood, deconditioning, medication effects, and the vascular disease that is common in this age group. Clinical studies suggest that asking about sexual function at the initial spine consultation, rather than after surgery, changes what gets treated. Some men will need both problems addressed, sequentially or in parallel.
For men whose symptoms persist after the structural question has been answered, the next step is a proper assessment of what is driving the erectile dysfunction now. If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans starting with a free online assessment at questionnaire.getonyxmd.com, including the triple-mechanism sublingual formulation reviewed at VAST.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
- Lenga P, Fleige R, Blumenstock MC, Ganzinger M, Ille S, Dugas M, Krieg SM. Multidimensional burden of low back pain: a prospective cross-sectional study of patient-reported outcomes and sociodemographic factors at a tertiary neurosurgical center. Brain and Spine. 2026;6:105905. doi:10.1016/j.bas.2025.105905
- Günerhan G, Aykanat C, Uçkun OM, et al. Evaluation of sexual function in patients with lower lumbar disc herniation: a comparison of pre- and postoperative status. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2024;85(1):26-31. doi:10.1055/s-0042-1759824
- Moradi Z, Shahali S, Ahmadi F, Montazeri A. The implications of surgery on sexual dysfunction in patients with lumbar disc herniation with cauda equina syndrome: a systematic review. BMC Musculoskeletal Disorders. 2025;26(1):489. doi:10.1186/s12891-025-08736-3
- Akbaş NB, Dalbayrak S, Külcü DG, Yilmaz M, Yilmaz T, Naderi S. Assessment of sexual dysfunction before and after surgery for lumbar disc herniation. Journal of Neurosurgery: Spine. 2010;13(5):581-586. doi:10.3171/2010.5.SPINE09906
- Akca N, Ozdemir B, Kanat A, Batcik OE, Yazar U, Zorba OU. Describing a new syndrome in L5-S1 disc herniation: sexual and sphincter dysfunction without pain and muscle weakness. Journal of Craniovertebral Junction and Spine. 2014;5(4):146-150. doi:10.4103/0974-8237.147076
- Sahin CU, Aydin M, Kalkisim S, Sahin H, Arslan FC. Comparison of preoperative and postoperative sexual dysfunction in male patients with lumbar disc herniation. Turkish Neurosurgery. 2022;32(3):442-448. doi:10.5137/1019-5149.JTN.35810-21.2
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.